Anaphylaxis overview: Difference between revisions
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
''Anaphylaxis'' is an [[acute (medical)|acute]] systemic (multi-system) and severe Type I Hypersensitivity [[allergy|allergic]] reaction in humans and other [[mammal]]s. Anaphylaxis occurs when a person or animal is exposed to a trigger substance, called an [[allergen]], to which they have already become sensitized. Minute amounts of allergens may cause a life-threatening anaphylactic reaction. Anaphylaxis may occur after ingestion, skin contact, injection of an allergen or, in rare cases, inhalation. The mainstay of | ''Anaphylaxis'' is an [[acute (medical)|acute]] systemic (multi-system) and severe Type I Hypersensitivity [[allergy|allergic]] reaction in humans and other [[mammal]]s. Anaphylaxis occurs when a person or animal is exposed to a trigger substance, called an [[allergen]], to which they have already become sensitized. Minute amounts of allergens may cause a life-threatening anaphylactic reaction. Anaphylaxis may occur after ingestion, skin contact, injection of an allergen or, in rare cases, inhalation. The mainstay of prevention is to avoid the allergen. <ref name="pmid28800865">{{cite journal| author=LoVerde D, Iweala OI, Eginli A, Krishnaswamy G| title=Anaphylaxis. | journal=Chest | year= 2018 | volume= 153 | issue= 2 | pages= 528-543 | pmid=28800865 | doi=10.1016/j.chest.2017.07.033 | pmc=6026262 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28800865 }} </ref> The mainstay of treatment is epinephrine. <ref name="pmidDOI: 10.1542/peds.2016-4006">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=DOI: 10.1542/peds.2016-4006 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | ||
==References== | ==References== | ||
Revision as of 20:16, 8 April 2021
|
Anaphylaxis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anaphylaxis overview On the Web |
|
American Roentgen Ray Society Images of Anaphylaxis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
Anaphylaxis is an acute systemic (multi-system) and severe Type I Hypersensitivity allergic reaction in humans and other mammals. Anaphylaxis occurs when a person or animal is exposed to a trigger substance, called an allergen, to which they have already become sensitized. Minute amounts of allergens may cause a life-threatening anaphylactic reaction. Anaphylaxis may occur after ingestion, skin contact, injection of an allergen or, in rare cases, inhalation. The mainstay of prevention is to avoid the allergen. [1] The mainstay of treatment is epinephrine. [2]
References
- ↑ LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). "Anaphylaxis". Chest. 153 (2): 528–543. doi:10.1016/j.chest.2017.07.033. PMC 6026262. PMID 28800865.
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1542/peds.2016-4006 DOI: 10.1542/peds.2016-4006 Check
|pmid=value (help).